Article Details

Ocugen to initiate Phase III trial of gene therapy for retinitis pigmentosa

Retrieved on: 2024-04-10 14:58:16

Tags for this article:

Click the tags to see associated articles and topics

Ocugen to initiate Phase III trial of gene therapy for retinitis pigmentosa. View article details on hiswai:

Excerpt

The gold standard of business intelligence. ... The Phase III study will enrol 150 participants in two arms; one arm of patients with the RHO gene ...

Article found on: www.clinicaltrialsarena.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo